Behavioral and analgesic effects induced by administration of nifedipine and nimodipine

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 1, 1996, Pages 93-98

  Martin M I ^a   Del Val, V L ^a   Colado, M I ^a   Goicoechea, C ^a   Alfaro, M J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Analgesia; Anxiety; Behavior; Holeboard; Nifedipine; Nimodipine; Pain

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; NIFEDIPINE; NIMODIPINE;

ANALGESIA; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; LOCOMOTION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL; VOCALIZATION;

ANIMALIA;

EID: 0030249434     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02289-9     Document Type: Article

References (49)

1. 1. Albonetti, M. E.; Farabollini, F. Behavioral responses to single and repeated restraint in male and female rats. Behav. Proc. 28:97-110; 1992.
2. 2. Antkiewicz-Michaluk, L.; Romanska, I.; Michaluk, J.; Vetulani, J. Role of calcium channels in effects of antidepressant drugs on responsiveness to pain. Psychopharmacology (Berlin) 105:269-74. 1991.
3. 3. Baeyens, J. M.; Del Pozo, E. Interactions between calcium channel blockers and noncardiovascular drugs: Interactions with drugs acting at the neuromuscular or the CNS level. Pharmacol. Toxicol. 62:59-63; 1988.
4. 4. Baeyens, J. M.; Esposito, E.; Ossowska, G.; Saanin, R. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol. 137:9-13; 1987.
5. 5. Basilico, L.; Parolaro, D.; Rubino, T.; God, E.; Giagnoni, G. Influence of ω-conotoxin on morphine analgesia and withdrawal syndrome in rats. Eur. J. Pharmacol. 218:75-81; 1992.
6. 6. Benedek, G.; Szikszay, M. Potentiation of thermorregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol. Res. Commun, 16:1009-1018; 1984.
7. 7. Ben-Sreti, M. M.; Gonzales, J. P.; Sewelt, R. D. Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan induced analgesia. Eur. J. Pharmacol. 90:385-391; 1983.
8. 8. Bolger, G. T.; Weissman, B. A.; Skolnick, P. The behavioral effects of the calcium agonist BAY K 8644 in the mouse: Antagonism by the calcium channel antagonist nifedipine. Naunyn Schmiedebergs Arch. Pharmacol. 328:373-377; 1985.
9. 9. Braunwald, E. Mechanism of action of calcium channel blocking agents. N. Engl. J. Med. 307:1618-1627; 1982.
10. 10. Bussey, H. I.; Talbert, R. L. Promising uses of calcium channel blocking agents. Pharmacotherapy 4:137-143; 1984.
11. 11. de Cabo, C.; Colado, M. I.; Pujol, A.; Martín, M. I.; Viveros, M. P. Naltrexone administration effects on regional brain monoamines in developing rats. Brain Res. Bull. 34(4):395-406; 1994.
12. 12. Carrol, M. N., Jr.; Lim, R. K. S. Observations on the neuropharmacology of morphine and morphine-like analgesia. Arch. Int. Pharmacodyn. CXXV:383-403; 1960.
13. 13. DeSarro, G. B.; Meldrum, B. S.; Nistico, G. Anticonvulsivant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmacol. 93:247-256;, 1988.
14. 14. Dierssen, M.; Flórez, J.; Hurlé, M. A. Calcium channel modulation by dihydropyridine modifies sufentanil-induced antinociception acute and tolerant conditions. Naunyn Schmiedebergs Arch. Pharmacol. 342:559-565; 1990.
15. 15. Dubovsky, S. L.; Franks, R. D. Intracellular calcium ions in affective disorders: A review and a hypothesis. Biol. Psychiatry 18:781-797; 1983.
16. 16. Dubovsky, S. L.; Franks, R. D.: Alien, S.; Murphy, J. Calcium antagonists in mania: A double-blind study of verapamil. Psychiatr. Res. 18:309-320; 1986.
17. 17. Duhm, B.; Maul, W.; Medenwald, H.; Patzschke, K.: Wegner, L. A. Tierexperimentelle untersuchungen zur Pharmakokinetik und Biotransformation von radioaktiv markiertem 4-(2′-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäure dimethylester. Arzneimittleforschung 22:42-52; 1972.
18. 18. File, S. E. What can be learned from the effects of benzodiazepines on exploratory behavior. Neurosci. Biobehav. Rev. 9:45-54; 1985.
19. 19. Giannini, A. J.; Houser, W. L., Jr.: Loiselle, R. H.; Giannini, M. C.; Price, A. Antimaniac effects of verapamil. Am. J. Psychiatry 141:1602-1603; 1984.
20. 20. Gray, J. A. Comment on Archer's paper: Sex differences in the emotional behavior of laboratory mice. Br. J. Psychol. 70:35; 1979.
21. 21. Grebb, J. A. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice. Life Sci. 83:2375-2381; 1986.
22. 22. Gurdal, H.; Sara, Y.; Tulunay, F. C. Effects of calcium channel blockers on formalin-induced nociception and inflammation in rats. Pharmacology 44:290-296. 1992.
23. 23. Hoffmeister, F.; Bellemann, H. P.; Benz, W.; Van den Kerckhoff. Psychotropic actions of Nimodipine. In: Betz, E.; Deck, K.; Hoffmeister, F., eds. Nimodipine: Pharmacological and clinical properties. New York: Schattauer Verlag; 1984.
24. 24. Hoffmeister, F.; Tettenborn, D. Calcium antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate μ-receptor agonist and neuropharmacological actions in rodents. Psychopharmacology (Berlin) 90:299-307; 1986.
25. 25. Hoschl, C. Verapamil for depression? (letter) Am. J. Psychiatry 140:1100; 1983.
26. 26. Illich, P. A.; Salinas, J. A.; Grau, J. W. Latent inhibition, overshadowing, and blocking of a conditioned antinociceptive response in spinalized rats. Behav. Neural. Biol. 62:140-150; 1994.
27. 27. Little, H. J.; Dolin, S. J.; Halsey, M. J. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci. 39:2059-2065; 1986.
28. 28. Martín, M. I.; Lizasoaiń, I.; Leza, J. C. Calcium channel blockers: Effect on morphine-induced hypermotility. Psychopharmacology (Berlin) 101:267-270; 1990.
29. 29. Mickley, G. A.; Mulrihill, M. A.; Postler, M. A. Brain μ and δ opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse. Psychopharmacology (Berlin) 101:332-337; 1990.
30. 30. Millan, M. J. κ-Opioid receptors and analgesia. Trends Pharmacol. Sci. 11:70-75; 1990.
31. 2+ channel blockers. Eur. J. Pharmacol. 217:137-141; 1992.
32. 32. Miranda, H. F.; Pelissier, T.; Sierralta, F. Analgesic effects of intracerebroventricular administration of calcium channel blockers in mice. Gen. Pharmacol. 24:201-204; 1993.
33. 33. Naranjo, J. R.; Sánchez-Franco, F.; Garzón, J.; del Río, J. Analgesic activity of substance P in rats: Apparent mediation by metenkephalin release. Life Sci. 30:441-446; 1982.
34. 34. Omote, K.; Sonoda, H.; Kawamata, M.; Iwasaki, H.; Namiki, A. Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord. Anesthesiology 79:746-752; 1993.
35. 35. Paulson, P. E.; Robinson. T. E. Relationship between circadian changes in spontaneous motor activity and vs. ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav. Neurosci. 108:624-635; 1994.
36. 36. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of openclosed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
37. 37. Pollack, M. H.; Rosenbaum, J. F. Verapamil in the treatment of recurrent unipolar depression. Biol. Psychiatry 22:779-782; 1987.
38. 38. del Pozo, E.; Caro, G.; Baeyens, J. M. Analgesic effects of several calcium channel blockers in mice. Eur. J. Pharmacol. 137:155-160; 1987.
39. 39. Pujol, A.; de Cabo, C.; Martín, M. I.; Viveros, M. P. A developmental study on stress-induced antinociception measured by the tail electric stimulation test. Pharmacol. Biochem. Behav. 46:373-376; 1993.
40. 40. Royce, J. R. On the construct validity of open-field measures. Psychol. Bull. 84:1098-1106; 1977.
41. 41. Schmid, C.; Xie, J.; Fournié-Zaluski, M. C.; Peyroux, J.; Roques, B. P. Antinociception and endogenous enkephalins. Adv. Biosci. 75:475-478; 1989.
42. 2+-channel blocker ω-conotoxin in conscious rats. Am. J. Physiol. 259:427; 1990.
43. 2+ antagonists. Trends Pharmacol. Sci. 6:309-310; 1985.
44. 44. Steenbergen, H. L.; Farabollinu, F.; Heinsbroek, R. P. W.; van de Poll, N. E. Sex-dependent effects of aversive stimulation on holeboard and elevated plus-maze behavior. Behav. Brain Res. 43:159-165; 1991.
45. 45. Treit, D.; Fundytus, M. Thigmotaxis a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31:959-962; 1989.
46. 46. Valle, F. P.; Bols, R. J. Age factors in sex differences in open field activity of rats. Anim. Learn. Behav. 4:457-460; 1976.
47. 47. Viveros, M. P.; Pujol, A.; de Cabo, C.; Martin, M. I. A study on the development of nociceptive responses in pre and postwealing rats: The tail electric stimulation test as a suitable methodology. Methods Find. Exp. Clin. Pharmacol. 15:31-33; 1993.
48. 48. Wilson, C. A.; González, I.; Farabollini, F. Behavioral effects in adulthood of neonatal manipulation of brain serotonin levels in normal and androgenized females. Pharmacol. Biochem. Behav. 41:91-98; 1992.
49. 49. Wong, C. H.; Wu, W. H.; Yarmush, J.; Zbuzek, V. K. An antinociceptive effect of the intraperitoneal injection of nifedipine in rats, measured by tail-flick test. Life Sci. 53:249-253; 1993.